Company / Revenue per Share
NextCure, Inc. Revenue per Share History
FY2019-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$1.44
FY2021
5-year range
$0.41 / $4.62
FY2019-FY2021
Trend
+252.6%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share changed +253% YoY in FY2021, a notable deviation from the 2-year average annual change of +81%.
Based on SEC 10-K filings.
1.44 in FY2021.
Declined from $4.62 to $1.44 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, revenue per share increased 252.6% year-over-year.
Company context
Key Data Points
- Altman Z-Score -2.19 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | $1.44 | +252.6% |
| FY2020 | $0.41 | -91.2% |
| FY2019 | $4.62 | - |
As of FY2021 · SEC 10-K Annual Filings · Updated Jun 28, 2026